{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T13:51:49Z","timestamp":1770040309229,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s10067-021-05980-5","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T03:02:30Z","timestamp":1637031750000},"page":"1349-1357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7389-5576","authenticated-orcid":false,"given":"Ernesto","family":"Zavala-Flores","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9221-3040","authenticated-orcid":false,"given":"Jannin","family":"Salcedo-Matienzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1232-5200","authenticated-orcid":false,"given":"Ana","family":"Quiroz-Alva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8640-6658","authenticated-orcid":false,"given":"Alfredo","family":"Berrocal-Kasay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"5980_CR1","unstructured":"McGill COVID-19 Vaccine Tracker Team. COVID19 vaccine tracker. https:\/\/covid19.trackvaccines.org\/vaccines\/ Date Accessed 15 Aug 2021"},{"issue":"4","key":"5980_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S2665-9913(21)00037-0","volume":"3","author":"L Boekel","year":"2021","unstructured":"Boekel L, Hooijberg F, van Kempen ZLE, Vogelzang EH, Tas SW, Killestein J et al (2021) Perspective of patients with autoimmune diseases on COVID-19 vaccination. Lancet Rheumatol. 3(4):241\u2013e243. https:\/\/doi.org\/10.1016\/S2665-9913(21)00037-0","journal-title":"Lancet Rheumatol."},{"issue":"4","key":"5980_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S2665-9913(21)00039-4","volume":"3","author":"R Felten","year":"2021","unstructured":"Felten R, Dubois M, Ugarte-Gil MF, Chaudier A, Kawka L, Bergier H et al (2021) Vaccination against COVID-19: expectations and concerns of patients with autoimmune and rheumatic diseases. Lancet Rheumatol 3(4):243\u2013e245. https:\/\/doi.org\/10.1016\/S2665-9913(21)00039-4","journal-title":"Lancet Rheumatol"},{"key":"5980_CR4","doi-asserted-by":"publisher","first-page":"102649","DOI":"10.1016\/j.jaut.2021.102649","volume":"121","author":"HM Moutsopoulos","year":"2021","unstructured":"Moutsopoulos HM (2021) A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine. J Autoimmun 121:102649. https:\/\/doi.org\/10.1016\/j.jaut.2021.102649","journal-title":"J Autoimmun"},{"key":"5980_CR5","doi-asserted-by":"publisher","unstructured":"Connolly CM, Ruddy JA, Boyarsky BJ, Avery RK, Werbel WA, Segev DL et al (2021) Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220231","DOI":"10.1136\/annrheumdis-2021-220231"},{"key":"5980_CR6","doi-asserted-by":"publisher","unstructured":"Boyarsky BJ, Ruddy JA, Connolly CM, Ou MT, Werbel WA, Garonzik-Wang JM et al (2021) Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220289","DOI":"10.1136\/annrheumdis-2021-220289"},{"issue":"2","key":"5980_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.autrev.2013.07.007","volume":"13","author":"G Murdaca","year":"2014","unstructured":"Murdaca G, Orsi A, Span\u00f2 F, Puppo F, Durando P, Icardi G et al (2014) Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity. Autoimmun Rev 13(2):75\u201384. https:\/\/doi.org\/10.1016\/j.autrev.2013.07.007","journal-title":"Autoimmun Rev"},{"issue":"5","key":"5980_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/annrheumdis-2012-201393","volume":"72","author":"CC Mok","year":"2013","unstructured":"Mok CC, Ho LY, Fong LS, To CH (2013) Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case\u2013control study. Ann Rheum Dis 72(5):659\u2013664. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201393","journal-title":"Ann Rheum Dis"},{"key":"5980_CR9","doi-asserted-by":"publisher","unstructured":"Izmirly PM, Kim MY, Samanovic M, Fernandez-Ruiz R, Ohana S, Deonaraine KK (2021) Evaluation of immune response and disease status in SLE patients following SARS-CoV-2 vaccination. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.41937","DOI":"10.1002\/art.41937"},{"issue":"5","key":"5980_CR10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/vaccines9050435","volume":"9","author":"A Watad","year":"2021","unstructured":"Watad A, De Marco G, Mahajna H, Druyan A, Eltity M, Hijazi N et al (2021) Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination. Vaccines 9(5):435. https:\/\/doi.org\/10.3390\/vaccines9050435","journal-title":"Vaccines"},{"issue":"8","key":"5980_CR11","doi-asserted-by":"publisher","first-page":"e542","DOI":"10.1016\/S2665-9913(21)00181-8","volume":"3","author":"L Boekel","year":"2021","unstructured":"Boekel L, Kummer LY, van Dam KPJ, Hooijberg F, van Kempen Z, Vogelzang EH et al (2021) Adverse events after first COVID-19 vaccination in patients with autoimmune diseases. Lancet Rheumatol. 3(8):e542\u2013e545. https:\/\/doi.org\/10.1016\/S2665-9913(21)00181-8","journal-title":"Lancet Rheumatol."},{"key":"5980_CR12","doi-asserted-by":"publisher","unstructured":"Felten R, Kawka L, Dubois M, Ugarte-Gil MF, Fuentes-Silva Y, Piga M (2021) Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study. Lancet Rheumatol. https:\/\/doi.org\/10.1016\/S2665-9913(21)00221-6","DOI":"10.1016\/S2665-9913(21)00221-6"},{"issue":"8","key":"5980_CR13","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677\u20132686. https:\/\/doi.org\/10.1002\/art.34473","journal-title":"Arthritis Rheum"},{"issue":"9","key":"5980_CR14","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R (2019) 2019 European league against rheumatism\/American College of Rheumatology Classification Criteria for systemic lupus erythematosus. Arthritis Rheumatol. 71(9):1400\u20131412. https:\/\/doi.org\/10.1002\/art.40930","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"5980_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1177\/0961203310388445","volume":"20","author":"N Ruperto","year":"2011","unstructured":"Ruperto N, Hanrahan LM, Alarc\u00f3n GS, Belmont HM, Brey RL, Brunetta P et al (2011) International consensus for a definition of disease flare in lupus. Lupus. 20(5):453\u2013462. https:\/\/doi.org\/10.1177\/0961203310388445","journal-title":"Lupus."},{"issue":"7","key":"5980_CR16","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/art.41734","volume":"73","author":"JR Curtis","year":"2021","unstructured":"Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR et al (2021) American College of Rheumatology Guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases \u2013 version 1. Arthritis Rheumatol 73(7):1093\u20131107. https:\/\/doi.org\/10.1002\/art.41734","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"5980_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.md.0000104742.42401.e2","volume":"83","author":"BA Pons-Estel","year":"2004","unstructured":"Pons-Estel BA, Catoggio LJ, Cardiel MH et al (2004) The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among \u201cHispanics\u201d. Medicine (Baltimore) 83(1):1\u201317. https:\/\/doi.org\/10.1097\/01.md.0000104742.42401.e2","journal-title":"Medicine (Baltimore)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05980-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05980-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05980-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T11:03:14Z","timestamp":1651316594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05980-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["5980"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05980-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]},"assertion":[{"value":"20 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Cayetano Heredia Hospital ethics committee (code 039\u20132021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants in the present study gave verbal consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}